As of today, MCH said it has completed 159 “Watchman ... the updated device as part of the alternative procedure for people with atrial fibrillation not caused by a heart valve problem.

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

“Washington Regional is proud to offer this technology to our patients,” said Dr. Shaun Senter, a cardiologist with ...